Kala Bio (NASDAQ:KALA) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $(1.44) by 159.72 percent. This is a 149.43 percent increase over losses of $(1.74) per share from the same period last year. The company reported $0.010 in sales this quarter.